Abbott India Ltd., a prominent player in the pharmaceuticals and drugs industry, experienced a notable increase of 3.03% on May 2, 2025. The stock closed at Rs 30,750, just 3.74% shy of its 52-week high of Rs 31,900. This performance outpaced the broader market, with Abbott India outperforming its sector by 3.56%. The stock is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong upward trend. In comparison to the Sensex, which saw a modest gain of 0.28% after a flat opening, Abbott India’s performance over various time frames has been impressive. Over the past week, the stock rose by 3.54%, while it has gained 4.33% over the last month. In the longer term, Abbott India has shown significant growth, with a 19% increase over the past three months and a remarkable 80.95% rise over the last three years. The company's year-to-date performance stands at 3.93%, further highlighting its resilience in the current market landscape.

#TechnicalViews#FundamentalViews

137 likes·76 comments